The molecular weight markers market is estimated to register a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to expanding perseverance on genomics and proteomics technologies research and rising investment in R&D. The immense demand for personalized medicines for the treatment of genetic disorders and chronic diseases is a key factor aiding to the expansion of the market. Personalized medicines include the features of molecular weight markers for the study of an individual’s genes, genome and diseases.
The recent evolution in these molecular biology products authorizes the provision of a clearer background and sharp bands. Thereby, the demand for molecular weight marker products is expected expand in coming years and further drive the market expansion.
In 2017, an investment from Magnotta Foundation to fund Lyme disease research with USD 1.4 million, which requires particular study of these disease attributes through the application of molecular markers, expanded the popularity and significance of molecular markers in molecular biology.
GBP 17 million was invested by the University of Leeds in structural biology research, which would additionally involve the use of molecular markers in above 50% of their research activities. These vast investments in research specific areas that involve rising utilities of molecular research biology along with molecular markers are projected to boost the growth of the molecular marker market over the forecast period.
The Covid-19 pandemic had an unpleasant impact on the molecular weight markers. Both the demand and supply ware affected. The market suffered significant loss; however, the government’s steps and strategies have helped to neutralised the situation. This pandemic has encouraged the key players to implement advance technologies to overcome these challenges and expand the market growth.
Market Trends, Drivers, Restraints, and Opportunities
- The rising acquisition of personalized medicines along with an upsurge pivot on molecular biology research is anticipated to drive the demand for molecular weight marker products; this in turn is likely propelling the market growth during forecast period.
- Technological advancement in molecular biology products, which includes NGS and PCR along with high-quality molecular weight marker, is expected to spur the market growth in coming years.
- Lack of skilled professionals to conduct the research process and use these markers efficiently in the field of molecular weight markers is likely to impede the market of molecular weight markers
- R&D investment and technological advancement in molecular weight markers market are expected to offer lucrative opportunities for the market players.
Scope of the Report
The report on the molecular weight markers market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Molecular Weight Markers Market -Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Product (DNA Marker, Protein Marker, and RNA Marker) Application (PCR, Sequencing, Northern Blotting, Southern Blotting) Type (Prestained Marker, Unstained Marker, and Specialty Marker)
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report
Thermo Fisher Scientific, Inc.; F Hoffmann-La Roche Ltd; Merck KGaA; Agilent Technologies; QIAGEN; TAKARA BIO, INC.; Bio-Rad Laboratories, Inc.; Promega Corp; and New England Biolabs
Market Segment insights
The DNA marker segment is projected to constitute a large market share
Based on product, the molecular weight markers market is segregated into DNA marker, protein marker, and RNA marker. The DNA marker segment is expected to account for a key share of the market during the forecast period owing to application of proteomics study for clinical diagnostics and new drug discovery, which would aid the biotechnology companies and researchers.
PCR segment is expected to register a substantial CAGR
Based on application, the molecular weight markers market is divided into PCR, sequencing, northern blotting, and southern blotting. The PCR segment accounts for a key share of the market and is estimated to propel even further over the forecast period owing to a rising focus on RNA and DNA-based research. The growing demand for therapeutic products and advanced diagnostics has escalated the focus on genomics research. However, northern blotting and southern blotting segments are anticipated to expand at a rapid pace during the forecast period owing to rising drug discovery & clinical diagnostics researches.
Prestained marker segment is expected to grow at a robust pace
Based on type, the molecular weight markers market is divided into prestained marker, unstained marker, and specialty marker. The prestained marker segment is expected to account for a key share of the market during the forecast period owing to the vast application of this product for proteomics and genomics research. However, unstained marker segment is expected to register significant growth in coming years due to its ability to provide more accurate molecular weight determinations of the sample over its competitors.
North America is expected to dominate the market
In terms of regions, the market is broadly classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to expand at a robust CAGR during the forecast period. Presence of several large research biotechnology firms and laboratories including Amgen Inc. and CELGENE CORP. in this region are anticipated to boost the market growth over the coming years. However, the market of Asia Pacific is expected to exhibit a rapid growth rate in the coming years due to rising focus of biotechnology companies and CROs in this region for development and drug discovery.
Segments Covered in the Report
The molecular weight markers market has been segmented on the basis of
- DNA Marker
- Protein Marker
- RNA Marker
- Northern Blotting
- Southern Blotting
- Prestained Marker
- Unstained Marker
- Specialty Marker
- Asia Pacific
- North America
- Latin America
- Middle East & Africa
- Thermo Fisher Scientific Inc.
- F Hoffmann-La Roche Ltd
- Merck KGaA
- Agilent Technologies
- TAKARA BIO, INC.
- Bio-Rad Laboratories Inc.
- Promega Corp
- New England Biolabs
Key players competing in the molecular weight markers market include Thermo Fisher Scientific, Inc.; F Hoffmann-La Roche Ltd; Merck KGaA; Agilent Technologies; QIAGEN; TAKARA BIO, INC.; Bio-Rad Laboratories, Inc.; Promega Corp; and New England Biolabs
Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares. For instances, In November 2015, Merck took over Sigma-Aldrich Co. LLC. for USD 17 billion to strengthen its life science business.